Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4
You may also be interested in...
New Products In Brief
Merz Aesthetics’ Belotero Balance dermal filler; Gore’s Conformable Gore TAG for thoracic aortic aneurysms; Maquet’s Cardiosave intra-aortic balloon pump. More new products.
Galderma Jumps Into Dermal Filler Device Market With Q-Med Offer
Dermatology drug maker Galderma will be able to offer Q-Med’s Restylane dermal filler device alongside its Azzalure botulinum toxin for wrinkle treatment after acquiring Q-Med for up to $1.1 billion.
Galderma Jumps Into Dermal Filler Device Market With Q-Med Offer
Dermatology drug maker Galderma will be able to offer Q-Med’s Restylane dermal filler device alongside its Azzalure botulinum toxin for wrinkle treatment after acquiring Q-Med for up to $1.1 billion.